TEDCO’s Tammi Thomas Selected for Leadership Greater Washington 2022 Cohort

Published on :

TEDCO’s Tammi Thomas Selected for Leadership Greater Washington 2022 Cohort. Established over 35 years ago, LGW has developed nearly 2,000 executive-level leaders from the District of Columbia, Virginia, and Suburban Maryland through its flagship offering, the Signature Program. It’s an intensive ten-month program that exposes professionals to regional civic issues through education, connection, and knowledge sharing. With the purpose to leverage collective knowledge and resources to make the Greater Washington region a more dynamic and collaborative community. 

8 TEDCO Talks for Biotech and Life Science Enthusiasts in the BHCR

TEDCO Talks
Published on :

TEDCO Talks’, a video series launched by TEDCO in November 2020, serves as a platform for individuals to hear from thought leaders on economic development in the BioHealth Capital Region (BHCR), and particularly in Maryland. These 30-minute virtual ‘fireside chats’ cover a range of topics, such as advice to small businesses dealing with COVID-19, available funding programs and benefits, diversity and inclusion, and more.

TEDCO Talks Celebrates 25 Episodes

Published on :

TEDCO, Maryland’s economic engine for technology companies, released its 25th episode of its virtual series with CEO, Troy LeMaile-Stovall, called TEDCO Talks. The series features LeMaile-Stovall interviewing various thought leaders with connections to Maryland’s innovation ecosystem.

TEDCO and JLABS Discuss Innovation and Workforce Diversity in Maryland

Published on :

TEDCO recently launched ‘TEDCO Talks’, a series featuring thought leaders in economic development across the State of Maryland. On May 28th, TEDCO CEO & Executive Director, Troy LeMaile-Stovall interviewed Sally Allain, Head of JLABS @ Washington DC, about the future of the innovation ecosystem and the crucial role that JLABS will play in advancing the BioHealth Capital Region.

Veralox Therapeutics Announces Closing Of $16.6 Million Series A Financing And Announces New Board Members

Published on :

Veralox Therapeutics, a biotechnology company developing first-in-class small molecule therapeutics that treat the underlying pathologies of diseases with significant unmet medical needs, today announced the closing of a $16.6 million Series A financing. The round was led by Hatteras Venture Partners with participation from Genesys Capital, Point Field Partners and Alexandria Venture Investments as well as support from previous Veralox investors including Sanofi Ventures, JDRF T1D Fund, Maryland Momentum Fund, VTC Innovation Fund and TEDCO. The Company also announced that Ben Scruggs, PhD, principal at Hatteras Venture Partners, and Jamie Stiff, MBA, managing director at Genesys Capital, will join the Veralox Therapeutics board of directors.

Commission Appoints Amritha Jaishankar, Ph.D. as Executive Director, Maryland Stem Cell Research Fund (MSCRF)

Published on :

The Maryland Stem Cell Research Commission (Commission) announces the appointment of Amritha Jaishankar, PhD as Executive Director, Maryland Stem Cell Research Fund (MSCRF).

Maryland Stem Cell Research Commission Announces over $6 Million in Awards to Accelerate Cures

Published on :

The Maryland Stem Cell Research Commission (Commission) has approved funding to its second round of 2021 recipients for a total of $6,052,901. The Commission has also appointed Amritha Jaishankar, Ph.D., the current MSCRF Director – Programs & Strategic Alliances, to succeed Dan Gincel, Ph.D., as Executive Director of the MSCRF, effective May 14, 2021.